Witnesses: Universities Allied for Essential Medicines: Rachel Kiddell-Monroe, Chair. As individuals: Amir Attaran, Canada Research Chair, Law, Population Health, and Global Development Policy, University of Ottawa; Richard Dearden, Partner, Gowlings; Frederick M. Abbott, Edward Ball Eminent Scholar, Professor of International Law, Florida State University College of Law; Joshua Kimani, Canadian Medical Institute in Kenya. Doctors Without Borders: Emilou MacLean, Director, United States of America, Campaign for Access to Essential Medicines. GlaxoSmithKline Canada: Grant Perry, Vice-President, Public Affairs/Reimbursement. National Advocacy Committee of the Grandmothers to Grandmothers Campaign: Elizabeth Rennie, Member; Linda Watson, Member. Canada's Research-Based Pharmaceutical Companies (Rx & D): Russell Williams, President; Laurence Dotto, Director, Government and External Affairs. As an individual: Angus Livingstone, Managing Director, University-Industry Liaison Office, University of British Columbia. Canadian Generic Pharmaceutical Association: Jim Keon, President; Jody Cox, Director, Federal Government Relations. Intellectual Property Institute of Canada: David Schwartz, Chair, Biotechnology Patents Committee. AIDS and Rights Alliance for Southern Africa: Paula Akugizibwe, Advocacy Coordinator. International Federation of Pharmaceutical Manufacturers and Associations: Andrew Jenner, Director, Intellectual Property and Trade. Public Health Agency of Canada: Frank Plummer, Scientific Director General, National Microbiology Laboratory. World Trade Organization (WTO): Antony Taubman, Director, Intellectual Property Division. |